403 results on '"O'Sullivan, Matthew"'
Search Results
2. Longitudinal Choroidal Development in Preterm Infants
3. Brief psychological interventions in face-to-face and telehealth formats: a comparison of outcomes in a naturalistic setting
4. SARS-CoV-2 Seroprevalence in a Cohort of International Travellers Returning to Rural Australia: Enablers and Barriers to Containment of COVID-19
5. Emergence of Japanese encephalitis in Australia: a diagnostic perspective
6. Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance
7. ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial
8. The utility of SARS‐CoV‐2‐specific serology in COVID‐19 diagnosis
9. Astrocytes follow ganglion cell axons to establish an angiogenic template during retinal development
10. The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: a cross sectional study
11. Seroprevalence of Japanese encephalitis virus-specific antibodies in Australia following novel epidemic spread: protocol for a national cross-sectional study
12. Longitudinal Choroidal Development in Preterm Infants
13. Characterizing the acute antibody response of monkeypox and MVA‐BN vaccine following an Australian outbreak
14. Outbreak of community-acquired Staphylococcus aureus skin infections in an Australian professional football team
15. An evaluation of 4 commercial assays for the detection of SARS-CoV-2 antibodies in a predominantly mildly symptomatic low prevalence Australian population
16. Clinical evaluation of SARS-CoV-2 point-of-care antibody tests
17. Autoimmune inflammatory rheumatic diseases: Vaccines are important.
18. 2306. A serosurvey of healthcare workers caring for, or handling specimens from, individuals exposed to, or diagnosed with, SARS-CoV-2 infection (COVID-HEROES)
19. A Randomized Trial of Nafamostat for Covid-19
20. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
21. NRXN1α+/- is associated with increased excitability in ASD iPSC-derived neurons
22. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling
23. Clinician perceptions of research priorities for the management of noncritically ill patients admitted to hospital with SARS‐CoV‐2 infection.
24. Assessment procedures for structural wrought iron
25. Increased Ca2+ signaling in NRXN1α+/− neurons derived from ASD induced pluripotent stem cells
26. Pneumococcal bacteraemia in adults over a 10‐year period (2011–2020): a clinical and serotype analysis.
27. Anticoagulation Strategies in Non–Critically Ill Patients with Covid-19
28. Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial
29. Additional file 1 of ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial
30. CASSETTE—clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation: study protocol for a randomised controlled trial
31. A multicentre study of meticillin-resistant Staphylococcus aureus in acute bacterial skin and skin-structure infections in China: Susceptibility to ceftaroline and molecular epidemiology
32. Diabetes and hyperglycaemia among hospitalised patients with COVID ‐19 in Western Sydney: a retrospective cohort study
33. Anticoagulation and Antiplatelet Strategies in Non-Critically Ill Patients with Covid-19
34. Brief psychological interventions in face-to-face and telehealth formats: a comparison of outcomes in a naturalistic setting
35. LABORATORIES FOR INEQUALITY: STATE EXPERIMENTATION AND EDUCATIONAL ACCESS FOR ENGLISH-LANGUAGE LEARNERS
36. The seroprevalence of <scp>SARS‐CoV</scp> ‐2‐specific antibodies in children, Australia, November 2020 – March 2021
37. Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine
38. Emerging Genotype IV Japanese Encephalitis Virus Outbreak in New South Wales, Australia
39. Microbial Genotyping Systems for Infection Control
40. Shigella species epidemiology and antimicrobial susceptibility: the implications of emerging azithromycin resistance for guiding treatment, guidelines and breakpoints
41. SABRes: A tool for in silico detection of drug resistance conferring mutations in SARS-CoV-2 genomes
42. Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use
43. Diabetes and hyperglycaemia among hospitalised patients with COVID‐19 in Western Sydney: a retrospective cohort study.
44. ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial
45. Co-infection with SARS-COV-2 Omicron and Delta Variants Revealed by Genomic Surveillance
46. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey
47. Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
48. Investigating synapse formation and function using human pluripotent stem cell-derived neurons
49. Hollywood
50. SARS-CoV-2-specific IgM screening has low sensitivity for identifying potentially infectious travellers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.